Invivyd, Inc.

NASDAQ:IVVD

Biotechnology

Healthcare
$0.51 +4.16%

+$0.04 today

Market cap
$151.09M
Beta
0.63
P/E (TTM)
-3.9
EPS (TTM)
-$0.25
52W Low $0.48High $3.07

Volume 6.76M

Average 3.62M

Returns on capital

Invivyd, Inc. management

Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.

Return Metrics

ROE, ROIC & ROA over time

Management
Older years hidden. Sign in to unlock

ROE

-21.7%

avg -53.7%

ROIC

-22.8%

avg -102.4%

ROA

-19.0%

avg -72.0%

Analysis

ROA is currently the strongest return metric at -19.0% versus its period average of -72.0%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.

Leadership

Who runs the company?

Review the executive team, tenure, compensation, and ownership.

Management

Key executives, compensation & ownership

NameTitleCompensationAgeShares OwnedOwnership %

Robert D. Allen

Chief Scientific OfficerUSD 828.18K56——

Jill Andersen

Chief Legal Officer & Corporate SecretaryUSD 775.71K53283.77K0.21%

William E. Duke Jr.

CFO and Principal Financial & Accounting OfficerUSD 752.78K54——

Timothy Lee

Chief Commercial OfficerUSD 706.87K52——

Julie Green

Chief Human Resources OfficerUSD 542.35K50168.94K0.13%

Marc William Elia

CEO & Chairperson of the BoardUSD 85.5K50——

Katie Falzone

Senior Vice President of Finance————

Kristie Coneys Kuhl

Chief Communications Officer————

Rachael Gerlach

Senior Vice President of Regulatory Affairs————

Michael J. Mina

Chief Medical Officer & Chief Epidemiologist—42——

Compensation is shown in the reported currency; data updated Nov 7, 2026.

Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding Aug 18, 2026.

Insider trading

Are insiders buying or selling?

Follow recent insider purchases and sales reported on Form 4.

Insider Trading

SEC Form 4 transactions — last 12 months

Buys

1

$125,000.00

Sells

20

$531,320.86

Net Transaction Value

−$406,320.86

Net selling

Most Active

Andersen Jill

4 transactions

Transactions sorted by date, descending.

Open-market insider purchases and sales reported during the last 12 months
Type
Aug 18, 26

Andersen Jill

Direct

Sell$25.9K
Aug 18, 26

Allen Robert D. III

Direct

Sell$14.4K
Aug 18, 26

Duke William E.

Direct

Sell$15.5K
Aug 18, 26

Green Julie

Direct

Sell$15.5K
Aug 18, 26

Lee Timothy Edward

Direct

Sell$15.5K
Aug 17, 26

Duke William E.

Direct

Sell$16.1K
Aug 17, 26

Lee Timothy Edward

Direct

Sell$16.1K
Aug 17, 26

Green Julie

Direct

Sell$16.1K
Aug 17, 26

Andersen Jill

Direct

Sell$26.9K
Aug 17, 26

Allen Robert D. III

Direct

Sell$14.9K

1–10 of 21

Summary

Insiders reported 1 buys worth $125,000.00 and 20 sells worth $531,320.86 over the last 12 months. That adds up to net selling of $406,320.86. Andersen Jill was the most active insider with 4 transactions.

Growth analysis

Is management growing the business?

Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.

Growth Analysis

Historical CAGR & forward analyst estimates

Metric 10yr 5yr3yr Fwd Est.
EPSN/AN/AN/A
N/A1 analysts
RevenueN/AN/AN/A
+71.8% (5yr)1 analysts
Net IncomeN/AN/AN/A
N/A1 analysts
EBITN/AN/AN/A
N/A1 analysts

Analysis

Forward estimates point to Revenue at +71.8% (5yr), giving you a quick read on expected growth from here.

Competitors

Who does Invivyd, Inc. compete with?

Open similar companies to compare how their management teams allocate capital.

Questions

Management questions

Common questions about IVVD's management, answered from reported figures.

Who manages IVVD?

Invivyd, Inc. (IVVD) lists 10 active executives. The top listed executive is Marc William Elia, CEO & Chairperson of the Board.

Are IVVD insiders buying or selling?

Recent insider activity shows net buying of $22.67M.